With the public availability of ChatGPT 3.5 in fall 2022 at the latest, artificial intelligence in the sense of large language models (LLMs) is on everyone’s lips. However, it is often forgotten that this is only the provisional end point of decades of development of artificial intelligence, which, despite its great potential, still has many limitations. The question for practising doctors is how this technology can be used sensibly in everyday clinical practice – and how it should not be used.
Autoren
- Dr. med. Lukas Dürst
- Dr. med. Marc Oertle
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Multiple sclerosis
Vitamin D as an adjuvant in multiple sclerosis: statistical success and clinical limitations
- From symptom to diagnosis
Abdominal pain – internal hernias
- Artificial intelligence for COPD
A new era of personalized treatment
- Multiple sclerosis
Spirulina as adjuvant therapy? Reduction of cytokines and inflammation
- IBD and SARS-CoV-2
Vulnerable at the mercy of others
- Case Report
53-year-old female patient with palmoplantar keratoderma
- Diagnostics of respiratory viral infections
What is tested when and on whom?
- Incontinence